149 related articles for article (PubMed ID: 17901921)
1. Genetic association study and meta-analysis of the HTR2C Cys23Ser polymorphism and migraine.
Oterino A; Castillo J; Pascual J; Cayon A; Alonso A; Ruiz-Alegria C; Valle N; Monton F; Ruiz-Lavilla N
J Headache Pain; 2007 Sep; 8(4):231-5. PubMed ID: 17901921
[TBL] [Abstract][Full Text] [Related]
2. Serotonin 2C receptor gene Cys23Ser polymorphism: a candidate genetic risk factor of migraine with aura in Japanese population.
Kusumi M; Araki H; Ijiri T; Kowa H; Adachi Y; Takeshima T; Sakai F; Nakashima K
Acta Neurol Scand; 2004 Jun; 109(6):407-9. PubMed ID: 15147464
[TBL] [Abstract][Full Text] [Related]
3. Single nucleotide polymorphisms of the serotonin transporter gene in migraine--an association study.
Bayerer B; Engelbergs J; Savidou I; Boes T; Küper M; Schorn CF; Wissmann A; Knop D; Diener HC; Limmroth V
Headache; 2010 Feb; 50(2):319-22. PubMed ID: 19845785
[TBL] [Abstract][Full Text] [Related]
4. The role of the Cys23Ser (rs6318) polymorphism of the HTR2C gene in suicidal behavior: systematic review and meta-analysis.
González-Castro TB; Hernandez-Diaz Y; Juárez-Rojop IE; López-Narváez L; Tovilla-Zárate CA; Rodriguez-Perez JM; Sánchez-de la Cruz JP
Psychiatr Genet; 2017 Dec; 27(6):199-209. PubMed ID: 29049139
[TBL] [Abstract][Full Text] [Related]
5. Promoter and functional polymorphisms of HTR2C and suicide victims.
Videtic A; Peternelj TT; Zupanc T; Balazic J; Komel R
Genes Brain Behav; 2009 Jul; 8(5):541-5. PubMed ID: 19496825
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the functional brain-derived neurotrophic factor gene variant Val66MET in migraine.
Marziniak M; Herzog AL; Mössner R; Sommer C
J Neural Transm (Vienna); 2008 Sep; 115(9):1321-5. PubMed ID: 18478177
[TBL] [Abstract][Full Text] [Related]
7. HTR2C (cys23ser) polymorphism influences early onset in bipolar patients in a large European multicenter association study.
Massat I; Lerer B; Souery D; Blackwood D; Muir W; Kaneva R; Nöthen MM; Oruc L; Papadimitriou GN; Dikeos D; Serretti A; Bellivier F; Golmard JL; Milanova V; Del-Favero J; Van Broeckhoven C; Mendlewicz J
Mol Psychiatry; 2007 Sep; 12(9):797-8. PubMed ID: 17767148
[No Abstract] [Full Text] [Related]
8. Migraine and tumour necrosis factor gene polymorphism. An association study in a Sardinian sample.
Asuni C; Stochino ME; Cherchi A; Manchia M; Congiu D; Manconi F; Squassina A; Piccardi MP; Del Zompo M
J Neurol; 2009 Feb; 256(2):194-7. PubMed ID: 19253056
[TBL] [Abstract][Full Text] [Related]
9. Alcohol dehydrogenase 2 genotype and risk for migraine.
García-Martín E; Martínez C; Serrador M; Alonso-Navarro H; Navacerrada F; Agúndez JA; Jiménez-Jiménez FJ
Headache; 2010 Jan; 50(1):85-91. PubMed ID: 19486361
[TBL] [Abstract][Full Text] [Related]
10. Variation of the serotonin transporter gene SLC6A4 in the susceptibility to migraine with aura.
Todt U; Freudenberg J; Goebel I; Heinze A; Heinze-Kuhn K; Rietschel M; Göbel H; Kubisch C
Neurology; 2006 Nov; 67(9):1707-9. PubMed ID: 17101915
[TBL] [Abstract][Full Text] [Related]
11. No influence of 5-HTTLPR gene polymorphism on migraine symptomatology, comorbid depression, and chronification.
Wieser T; Dresler K; Evers S; Gaul C; König D; Hölzl D; Berger K; Nyholt D; Deufel T
Headache; 2010 Mar; 50(3):420-30. PubMed ID: 19438736
[TBL] [Abstract][Full Text] [Related]
12. An investigation of the 5-HT2C receptor gene as a migraine candidate gene.
Johnson MP; Lea RA; Curtain RP; MacMillan JC; Griffiths LR
Am J Med Genet B Neuropsychiatr Genet; 2003 Feb; 117B(1):86-9. PubMed ID: 12555241
[TBL] [Abstract][Full Text] [Related]
13. The relationship between homocysteine and genes of folate-related enzymes in migraine patients.
Oterino A; Toriello M; Valle N; Castillo J; Alonso-Arranz A; Bravo Y; Ruiz-Alegria C; Quintela E; Pascual J
Headache; 2010 Jan; 50(1):99-168. PubMed ID: 19619240
[TBL] [Abstract][Full Text] [Related]
14. HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSM-III-R psychiatric diagnoses.
Lappalainen J; Long JC; Virkkunen M; Ozaki N; Goldman D; Linnoila M
Biol Psychiatry; 1999 Sep; 46(6):821-6. PubMed ID: 10494451
[TBL] [Abstract][Full Text] [Related]
15. Evidence of syntaxin 1A involvement in migraine susceptibility: a Portuguese study.
Lemos C; Pereira-Monteiro J; Mendonça D; Ramos EM; Barros J; Sequeiros J; Alonso I; Sousa A
Arch Neurol; 2010 Apr; 67(4):422-7. PubMed ID: 20385907
[TBL] [Abstract][Full Text] [Related]
16. MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis.
Schürks M; Rist PM; Kurth T
Headache; 2010 Apr; 50(4):588-99. PubMed ID: 19925624
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor 3 (DRD3) polymorphism and risk for migraine.
García-Martín E; Martínez C; Serrador M; Alonso-Navarro H; Navacerrada F; Agúndez JAG; Jiménez-Jiménez FJ
Eur J Neurol; 2010 Sep; 17(9):1220-1223. PubMed ID: 20236178
[TBL] [Abstract][Full Text] [Related]
18. MTHFR C677T polymorphism and migraine risk: a meta-analysis.
Liu R; Geng P; Ma M; Yu S; Yang M; He M; Dong Z; Zhang W
J Neurol Sci; 2014 Jan; 336(1-2):68-73. PubMed ID: 24183284
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidases A and B gene polymorphisms in migraine patients.
Filic V; Vladic A; Stefulj J; Cicin-Sain L; Balija M; Sucic Z; Jernej B
J Neurol Sci; 2005 Feb; 228(2):149-53. PubMed ID: 15694196
[TBL] [Abstract][Full Text] [Related]
20. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk.
Kara I; Sazci A; Ergul E; Kaya G; Kilic G
Brain Res Mol Brain Res; 2003 Mar; 111(1-2):84-90. PubMed ID: 12654508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
